Arrowstreet Capital’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-10,014
| Closed | -$92K | – | 1592 |
|
|
2021
Q3 | $92K | Sell |
10,014
-43,269
| -81% | -$398K | ﹤0.01% | 1543 |
|
|
2021
Q2 | $599K | Sell |
53,283
-105,417
| -66% | -$1.19M | ﹤0.01% | 1653 |
|
|
2021
Q1 | $1.68M | Sell |
158,700
-46,158
| -23% | -$489K | ﹤0.01% | 1619 |
|
|
2020
Q4 | $2.22M | Buy |
204,858
+33,383
| +19% | +$362K | ﹤0.01% | 1560 |
|
|
2020
Q3 | $1.67M | Sell |
171,475
-3,904
| -2% | -$38K | ﹤0.01% | 1635 |
|
|
2020
Q2 | $1.4M | Buy |
+175,379
| New | +$1.4M | ﹤0.01% | 1637 |
|
|
2018
Q4 | – | Sell |
-26,500
| Closed | -$382K | – | 1427 |
|
|
2018
Q3 | $382K | Buy |
26,500
+15,039
| +131% | +$217K | ﹤0.01% | 947 |
|
|
2018
Q2 | $171K | Buy |
+11,461
| New | +$171K | ﹤0.01% | 1014 |
|
|
2017
Q2 | – | Sell |
-19,921
| Closed | -$239K | – | 1208 |
|
|
2017
Q1 | $239K | Buy |
+19,921
| New | +$239K | ﹤0.01% | 1178 |
|
|
2016
Q4 | – | Sell |
-73,550
| Closed | -$986K | – | 2138 |
|
|
2016
Q3 | $986K | Sell |
73,550
-41,897
| -36% | -$562K | ﹤0.01% | 1073 |
|
|
2016
Q2 | $1.24M | Sell |
115,447
-103,184
| -47% | -$1.11M | ﹤0.01% | 962 |
|
|
2016
Q1 | $2.3M | Buy |
218,631
+30,485
| +16% | +$320K | 0.01% | 761 |
|
|
2015
Q4 | $2.23M | Sell |
188,146
-10,947
| -5% | -$130K | 0.01% | 774 |
|
|
2015
Q3 | $2.32M | Buy |
199,093
+16,400
| +9% | +$191K | 0.01% | 711 |
|
|
2015
Q2 | $2.64M | Sell |
182,693
-3,738
| -2% | -$53.9K | 0.01% | 579 |
|
|
2015
Q1 | $2.6M | Sell |
186,431
-40,326
| -18% | -$563K | 0.02% | 548 |
|
|
2014
Q4 | $3.13M | Buy |
226,757
+59,598
| +36% | +$823K | 0.02% | 588 |
|
|
2014
Q3 | $2.05M | Buy |
167,159
+147,464
| +749% | +$1.81M | 0.01% | 582 |
|
|
2014
Q2 | $246K | Sell |
19,695
-2,983
| -13% | -$37.3K | ﹤0.01% | 902 |
|
|
2014
Q1 | $253K | Buy |
+22,678
| New | +$253K | ﹤0.01% | 1060 |
|